Tilray reported 11.56 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acasti Pharma 9.94 0.08 Mar/2021
Akebia Therapeutics 1.63K 1.6K Dec/2025
Aurora Cannabis 23.27 0 Mar/2026
Cronos Group 283.6 162.67 Jun/2026
Dianthus Therapeutics 3.8 1.53 Sep/2024
Divis Laboratories Ltd 84.22 25.87 Sep/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 29.03 7.58 Sep/2026
Knight Therapeutics 257.34 166.24 Dec/2025
Moderna 27.22 14.51 Jun/2023
Organigram Holdings 15.55 3.54 Jun/2026
Organon & Co 17.56 3 Sep/2026
Revvity 56.86 20.39 Sep/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Tilray 11.56 80.19 Sep/2025
Viatris 468.91 434.44 Sep/2026
Xeris Pharmaceuticals 92.28 16.23 Jun/2026
Zealand Pharma A/S 3.27 1.86 Mar/2026